Home › Funds › CLIFFORD SWAN INVESTMENT COUNSEL LLC › LH

CLIFFORD SWAN INVESTMENT COUNSEL LLC position in LH

LABCORP HOLDINGS INC · Health Care

CLIFFORD SWAN INVESTMENT COUNSEL LLC reported holding 99,480 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$30.7M, representing 1.11% of its reported portfolio and ranking #27 among its reported holdings. CLIFFORD SWAN INVESTMENT COUNSEL LLC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)99.48K sh
Reported value held$30.65M
Portfolio Weight1.11%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CLIFFORD SWAN INVESTMENT COUNSEL LLC's LH position evolved

CLIFFORD SWAN INVESTMENT COUNSEL LLC first disclosed a stake in LH in Q3 2023 at 76,039 shares (US$15.3M). The position peaked in Q3 2026 at 99,480 shares, worth US$30.7M. Across 13 filings, CLIFFORD SWAN INVESTMENT COUNSEL LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 99,480 shares valued at US$30.7M — a reduction of -813 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 76.04K $15.29M New
Q4 2023 81.35K $18.49M Add
Q1 2024 82.44K $18.01M Add
Q2 2024 86.00K $17.50M Add
Q3 2024 96.38K $21.54M Add
Q4 2024 98.00K $22.47M Add
Q1 2025 101.71K $23.67M Add
Q2 2025 104.01K $27.30M Add
Q3 2025 106.22K $30.49M Add
Q4 2025 104.35K $26.18M Reduce
Q1 2026 103.22K $27.54M Reduce
Q2 2026 100.29K $28.08M Reduce
Q3 2026 99.48K $30.65M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has CLIFFORD SWAN INVESTMENT COUNSEL LLC held LH?

CLIFFORD SWAN INVESTMENT COUNSEL LLC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CLIFFORD SWAN INVESTMENT COUNSEL LLC's current position in LH?

As of Q3 2026, CLIFFORD SWAN INVESTMENT COUNSEL LLC holds 99.48K shares of LH (LABCORP HOLDINGS INC), valued at $30.65M, representing 1.11% of its reported portfolio and ranking #27.

Has CLIFFORD SWAN INVESTMENT COUNSEL LLC been buying or selling LH?

In the latest 13F filing (Q3 2026), CLIFFORD SWAN INVESTMENT COUNSEL LLC reduced its position in LH. The position peaked in Q3 2026 at 99.48K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.